Banerjee S, Ghisoni E, Wolfer A, Ottevanger PB, et al. Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study. Clin Cancer Res 2025 Mar 18. doi: 10.1158/1078-0432.CCR-24-3368.
PMID: 40100121